Viewing Study NCT02532192


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-04-16 @ 7:06 AM
Study NCT ID: NCT02532192
Status: WITHDRAWN
Last Update Posted: 2016-01-06
First Post: 2015-08-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module